Related references
Note: Only part of the references are listed.
Article
Oncology
Molecular Targeted Therapies for Patients with Refractory Thyroid Cancer
C. Chougnet et al.
CLINICAL ONCOLOGY (2010)
Letter
Oncology
Optimal Chemotherapy for High-Risk Early-Stage Breast Cancer
Carl D. Atkins
JOURNAL OF CLINICAL ONCOLOGY (2010)
Article
Pathology
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts
T Inai et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Share Paper
